A study of the BCR repertoires of two patients with SLE before and after high‐dose glucocorticoid therapy showed that IGHV3 gene family usage decreased after treatment,59 but CDR3 region composition was similar at all time points. This evidence concerns the gene BCR and systemic lupus erythematosus.